Literature DB >> 23720354

Central nervous system involvement in anaplastic large cell lymphoma in childhood: results from a multicentre European and Japanese study.

Denise Williams1, Tetsuya Mori, Alfred Reiter, Wilhelm Woessman, Angelo Rosolen, Grazyna Wrobel, Jozsef Zsiros, Anne Uyttebroeck, Ildiko Marky, Marie-Cécile Le Deley, Laurence Brugières.   

Abstract

In an international study of systemic childhood ALCL, 12/463 patients had CNS involvement, three of which had isolated CNS disease. Comparative analysis of CNS positive and negative patients showed no difference in ALK positivity, immunophenotype, presence of B symptoms or other sites of disease. The lymphohistiocytic variant was over represented in the CNS positive group (36% vs. 5%). With multi-agent chemotherapy, including high dose methotrexate, Ara-C and intrathecal treatment, the event free and overall survival of the CNS positive group at 5 years were 50% (95%CI, 25-75%) and 74% (45-91%), respectively with a median follow up of 4.1 years.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CNS disease; anaplastic large cell lymphoma; childhood; lymphohistiocytic; non-Hodgkin lymphoma

Mesh:

Substances:

Year:  2013        PMID: 23720354     DOI: 10.1002/pbc.24591

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

Review 1.  Peripheral T cell lymphoma in Asia.

Authors:  Sanghui Park; Young Hyeh Ko
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

Review 2.  ALK Positive Anaplastic Large Cell Lymphoma With Pure Leptomeningeal Involvement: Unique Case Report and Review of the Literature.

Authors:  P C Bricker; W S Lesley; R Surapaneni
Journal:  Clin Neuroradiol       Date:  2014-01-10       Impact factor: 3.649

Review 3.  Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.

Authors:  Naoko Tsuyama; Kana Sakamoto; Seiji Sakata; Akito Dobashi; Kengo Takeuchi
Journal:  J Clin Exp Hematop       Date:  2017

4.  Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents.

Authors:  Andishe Attarbaschi; Oussama Abla; Leila Ronceray; Shweta Bansil; Simon Bomken; Birgit Burkhardt; Francecso Ceppi; Alan K S Chiang; Hema Dave; Alina Fedorova; Michael Henry; Janez Jazbec; Edita Kabickova; Rishi S Kotecha; Jelena Lazic; Jan Loeffen; Natalia Miakova; Tomoo Osumi; Marta Pillon; Apostolos Pourtsidis; Charlotte Rigaud; Gevorg Tamamyan; Sneha Tandon; Anne Uyttebroeck; Jamie Verdu-Amoros; Wilhelm Woessmann; Grazyna Wrobel; Lisa Giulino-Roth
Journal:  Blood Adv       Date:  2019-12-23

5.  IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.

Authors:  Nina Prokoph; Nicola A Probst; Liam C Lee; Jack M Monahan; Jamie D Matthews; Huan-Chang Liang; Klaas Bahnsen; Ivonne A Montes-Mojarro; Elif Karaca-Atabay; Geeta G Sharma; Vikas Malik; Hugo Larose; Sorcha D Forde; Stephen P Ducray; Cosimo Lobello; Qi Wang; Shi-Lu Luan; Šárka Pospíšilová; Carlo Gambacorti-Passerini; G A Amos Burke; Shahid Pervez; Andishe Attarbaschi; Andrea Janíková; Hélène Pacquement; Judith Landman-Parker; Anne Lambilliotte; Gudrun Schleiermacher; Wolfram Klapper; Ralf Jauch; Wilhelm Woessmann; Gilles Vassal; Lukas Kenner; Olaf Merkel; Luca Mologni; Roberto Chiarle; Laurence Brugières; Birgit Geoerger; Isaia Barbieri; Suzanne D Turner
Journal:  Blood       Date:  2020-10-01       Impact factor: 22.113

Review 6.  Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL.

Authors:  Lucy Hare; G A Amos Burke; Suzanne D Turner
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

Review 7.  The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).

Authors:  Ivonne A Montes-Mojarro; Julia Steinhilber; Irina Bonzheim; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Cancers (Basel)       Date:  2018-04-04       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.